Site priorities
Which sites to open, with protocol-specific rationale.
ONCOLOGY ENROLLMENT INTELLIGENCE
Choose the right sites.
Find patient opportunities.
We help oncology sponsors decide which sites to open and what they can realistically enroll—then identify protocol-matched patient opportunities around selected sites.
For biotech and clinical-development teams worldwide. Independent intelligence, alongside your clinical team and CRO.
Enrollment expectations
A defined time window, an estimated range and the assumptions behind it.
Patient opportunities
Site-level opportunity views and patient-level leads for authorized clinical review.
Solutions
One enrollment challenge. Two stages.
Start with your protocol and the stage your trial has reached.
01 / BEFORE SITE SELECTION
Site Selection & Feasibility Intelligence
Which sites should we open—and what can they realistically enroll?
Turn an existing protocol into a prioritized site plan. We combine patient opportunity, competition, investigator context and operating evidence to explain where the trial can work and what enrollment to expect.
- A prioritized site plan
- Realistic enrollment expectations
- Risks that could change the plan
02 / AFTER SITES ARE SELECTED
Patient Identification & Enrollment Intelligence
Where are the patient opportunities around the sites we already selected?
Apply protocol criteria to permitted clinical and real-world evidence around selected or active sites. We deliver both aggregate opportunity views and patient-level leads that authorized clinical teams can verify and act on.
- Center and regional opportunity views
- Patient-level leads for review
- An actionable review handoff
How It Works
From protocol to a usable enrollment plan.
Define the trial and the decision
Connect the relevant evidence
Analyze and review
Deliver and hand off
Company
An independent view that fits your trial team.
We bring evidence together around the enrollment question—not around ownership of one dataset. The aim is a usable site plan or patient-opportunity handoff that complements sponsor and CRO work.
Kevin leads company strategy, product and commercial relationships. Allen leads technology and clinical-intelligence methodology. Each engagement identifies its analysts, reviewers and sponsor or clinical-team handoff. Additional expertise is agreed where needed.
Meet the team →
ONCOLOGY ENROLLMENT INTELLIGENCE
Where is your trial today?
Tell us whether you are choosing sites or working with sites already selected. Start with non-confidential context; we will define the relevant deliverable and access arrangements together.